Skip to main content
University of Wisconsin–Madison
UW Crest
Ophthalmology and Visual Sciences
  • Home
  • About Us Expand Collapse
    • About Us
    • Alumni
    • Annual Report / Newsletter
    • Careers
    • Directory
    • Giving
    • Leadership
  • Education
  • Research Expand Collapse
    • A-EYE Research Unit
    • Clinical Eye Research Unit
    • Laboratories
    • Publications
    • Research Resources
    • Vision Research Core
    • Vision Research Training Program
    • WAIVS
    • Wisconsin Reading Center
  • Global Ophthalmology
  • Patients
  • Careers
  • People First
  • Events
  • Giving
  • News

COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients.

Posted on October 20, 2022

PubMed ID: 36298623 Author(s): Elnahry AG, Al-Nawaflh MY, Gamal Eldin AA, Solyman O, Sallam AB, Phillips PH, Elhusseiny AM. COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients. Vaccines (Basel). 2022 Oct 20;10(10):1758. doi: …

Posted in Ayman Elnahry, Publications

University of Wisconsin on the Cutting Edge of Global Ophthalmology Curriculum

Posted on October 14, 2022

The University of Wisconsin Department of Ophthalmology and Visual Sciences (DOVS) is attracting attention at home and abroad for its global ophthalmology (GO) curriculum. Yasmin S. Bradfield, MD and Hannah Baker, MA presented the curriculum …

Posted in Cat Burkat, Featured News, Global Ophthalmology, Yasmin BradfieldTagged Education, global eye health, global ophthalmology

IZOKIBEP (IL-17A)

Posted on October 7, 2022

To assess the safety, tolerability, and immunogenicity of izokibep in subjects with active non-infectious, intermediate-, posterior- or pan-uveitis requiring high-dose steroids.

Posted in Clinical Trials, Laura Kopplin, Non-Infectious, UveitisTagged clinical trial, research, Uveitis

GALE

Posted on October 7, 2022

To assess the long-term efficacy and safety of multiple intravitreal injections of APL-2 in subjects with geographic atrophy secondary to age-related macular degeneration.

Posted in Age-related Macular Degeneration, Clinical Trials, Mihai Mititelu, OngoingTagged age-related macular degeneration, clinical trial, research

CONCERTO

Posted on October 7, 2022

To determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD).

Posted in Actively Recruiting, Age-related Macular Degeneration, Clinical Trials, Sarah NehlsTagged age-related macular degeneration, clinical trial, research

VILLA

Posted on October 7, 2022

To evaluate safety and tolerability of the Port Delivery System (PDS) in patients with neovascular age-related macular degeneration (nAMD).

Posted in Age-related Macular Degeneration, Clinical Trials, Michael AltaweelTagged age-related macular degeneration, clinical trial, research

HONU

Posted on October 7, 2022

The purpose of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced AMD stages.

Posted in Actively Recruiting, Age-related Macular Degeneration, Clinical Trials, Mihai MititeluTagged age-related macular degeneration, clinical trial, research

Perspectives on a Novel Culturally Tailored Diabetes Self-Management Program for African Americans: A Qualitative Study of Healthcare Professionals and Organizational Leaders.

Posted on October 6, 2022

PubMed ID: 36232115 Author(s): Wen MJ, Maurer M, Schwerer L, Sarkarati N, Egbujor UM, Nordin J, Williams SD, Liu Y, Shiyanbola OO. Perspectives on a novel culturally tailored diabetes self-management program for african americans: a …

Posted in Publications, Yao Liu

Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 30.

Posted on October 1, 2022

PubMed ID: 35660417 Author(s): Agrón E, Domalpally A, Cukras CA, Clemons TE, Chen Q, Lu Z, Chew EY, Keenan TDL; AREDS and AREDS2 Research Groups. Reticular pseudodrusen: The third macular risk feature for progression to …

Posted in Amitha Domalpally, Publications, WRC
  • Previous page
  • 1
  • 48
  • 49
  • You're on page 50
  • 51
  • 52
  • 635
  • Next page

Archives

Categories

Site footer content



University logo that links to main university website


Quick Links

  • News
  • Contact Us
  • Giving
  • Intranet Login
  • UW-Madison School of Medicine and Public Health

Contact Us

  • 2828 Marshall Court
    Madison, WI 53705
    • facebook
    • instagram
    • linkedin

Website feedback, questions or accessibility issues: webmaster@ophth.wisc.edu.

This site was built using the UW Theme | Privacy Notice | © 2026 Board of Regents of the University of Wisconsin System.